Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception

Clinical trial NCT01429116 · COMPLETED

Trial details

NCT number: NCT01429116
Sponsor: Vanda Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-24-Hour Sleep-Wake Disorder

Start date: 2011-10-01
Primary completion: 2015-01-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.